A startup has developed an artificial intelligence algorithm that it says can analyze results from an eye scanner and detect signs of Alzheimer’s 20 years before symptoms develop. The tool is part of broader work by startups and researchers to harness AI to unlock the mysteries of the disease.

Medical office buildings remain in high demand in a weak real estate market. The story cites the August sale of Banner – University North Campus, which encompasses the UArizona Cancer Center, for $134 million.

Media and health agencies are reporting a noticeable increase in child poisoning cases associated with THC edibles. The Arizona Poison and Drug Information Center at the R. Ken Coit College of Pharmacy reports a decrease in THC-related calls but underscored the persistence of incidents involving edibles.

The Drug Enforcement Agency received a recommendation to reclassify cannabis as a Schedule III drug, a move that would be a boon to research and patient care.

On Oct. 24, legislators, health law experts and others will dicsuss the current state of telehealth policy at the Arizona Telemedicine Program’s annual summit.

Problems with edible cannabis products in Arizona spiked in 2020 during the pandemic and have stayed at a heightened number since voters legalized recreational marijuana that year.

Arizona health officials this week scaled back the state's COVID-19 dashboard and declared the disease "a common respiratory illness."

A new study found that reactions such as chills, fatigue, headache and malaise that can follow vaccination may be signs of a vigorous immune response.

Presenting at the Alzheimer’s Research and Prevention Foundation’s annual conference in Phoenix, Roberta Diaz Brinton, PhD, director of the UArizona Center for Innovation in Brain Science, cited chronic conditions that could lead to Alzheimer's disease.